Results 51 to 60 of about 202 (90)
Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks. [PDF]
J Antimicrob ChemotherSuárez-García I, Alejos B, Moreno C, Martín Torres J, Masiá M, García-Fraile LJ, Riera M, Dalmau D, Rodríguez-Rosado R, Muga R, Moreno S, Jarrín I, CoRIS cohort
. +12 moreeuropepmc +1 more sourceGenotyping, sequencing and analysis of 140,000 adults from Mexico City. [PDF]
Nature, 2023 Ziyatdinov A, Torres J, Alegre-Díaz J, Backman J, Mbatchou J, Turner M, Gaynor SM, Joseph T, Zou Y, Liu D, Wade R, Staples J, Panea R, Popov A, Bai X, Balasubramanian S, Habegger L, Lanche R, Lopez A, Maxwell E, Jones M, García-Ortiz H, Ramirez-Reyes R, Santacruz-Benítez R, Nag A, Smith KR, Damask A, Lin N, Paulding C, Reppell M, Zöllner S, Jorgenson E, Salerno W, Petrovski S, Overton J, Reid J, Thornton TA, Abecasis G, Berumen J, Orozco-Orozco L, Collins R, Regeneron Genetics Center, Mexico City Prospective Study, Baras A, Hill MR, Emberson JR, Marchini J, Kuri-Morales P, Tapia-Conyer R. +48 moreeuropepmc +1 more sourceDeterminants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the relativity cohort. [PDF]
AIDSTroya J, Montes ML, Galindo MJ, Sánchez-López MB, Pelazas-González R, Torralba M, Díaz de Santiago A, Fanjul F, Rodríguez A, Cabello A, Crusells-Canales MJ, Navarro MDC, Aguilera M, Hidalgo C, Morano LE, Vinuesa-García D, David CA, Bernal E, Martínez-Álvarez RM, Romero A, Tiraboschi J, Gimeno-García A, Ferreira EM, Losa-García JE, Pedrero-Tomé R, Buzón-Martín L. +25 moreeuropepmc +1 more sourceLung function and radiological findings 1 year after COVID-19: a prospective follow-up. [PDF]
Respir Res, 2022 Tarraso J, Safont B, Carbonell-Asins JA, Fernandez-Fabrellas E, Sancho-Chust JN, Naval E, Amat B, Herrera S, Ros JA, Soler-Cataluña JJ, Rodriguez-Portal JA, Andreu AL, Marín M, Rodriguez-Hermosa JL, Gonzalez-Villaescusa C, Soriano JB, Signes-Costa J, COVID-FIBROTIC study team. +17 moreeuropepmc +1 more sourceHLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancer. [PDF]
OncoimmunologyRuiz-Lorente I, Gimeno L, López-Abad A, Cubillana PL, Aparicio TF, Egea LJA, Avilés JM, Iñiguez GD, Martínez-Valls PLG, Server G, Ferri B, Campillo JA, Galindo F, Martínez-Sánchez MV, Minguela A. +14 moreeuropepmc +1 more sourcePersonalized Blood Pressure Targeting After Endovascular Therapy for Acute Ischemic Stroke: A Randomized Clinical Trial.
JAMA NeurolCamps-Renom P, Guasch-Jiménez M, Álvarez-Cienfuegos J, López-Hernández N, Rodríguez-Campello A, Tejada-Meza H, López-Mesonero L, Albert-Lacal L, Freijo-Guerrero MM, Tarruella-Hernández D, Flores A, Cabezas-Rodríguez JA, Fernández-Vidal JM, Martínez-Domeño A, Pérez de la Ossa N, Ramos-Pachón A, Aguilera-Simón A, Marín R, Ezcurra-Díaz G, Lambea-Gil Á, Silva Y, Corona-García DJ, Giralt-Steinhauer E, Marta-Moreno J, Vizcaya-Gaona JA, Sanz-Monllor A, Luna A, López Morales M, Ustrell X, Moniche F, Solà-Roca J, Wang X, Anderson CS, Prats-Sánchez L, Martí-Fàbregas J, HOPE Study Group. +35 moreeuropepmc +1 more source